Dalton Chief Investment Officer Interviewed by Nikkei Business on Why Poison Pills Do Not Work

Dalton CIO, James B. Rosenwald III, recently interviewed with Nikkei Business, discussing recent announcements by Aska Pharmaceutical and Bunka Shutter to potentially implement a poison pill in order to block shareholder efforts to have each company consider going private.  The link to the interview is here (subscription required, in Japanese):